Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations.

Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations. Ethn Dis. 2020;30(3):429-432 Authors: Lackland DT, Sims-Robinson C, Jones Buie JN, Voeks JH Abstract The randomized clinical trial (RCT) has long been recognized as the 'gold standard' for developing evidence for clinical treatments and vaccines; however, the successful implementation and translation of these findings is predicated upon external validity. The generalization of RCT findings are jeopardized by the lack of participation of at-risk groups such as African Americans, with long-recognized disproportional representation. Distinct factors that deter participation in RCTs include distrust, access, recruitment strategies, perceptions of research, and socioeconomic factors. While strategies have been implemented to improve external validity with greater participation among all segments of the population in RCTs, the coronavirus disease 2019 (COVID-19) pandemic may exacerbate disparities in RCT participation with the potential impact of delaying treatment development and vaccine interventions that are applicable and generalizable. Thus, it is essential to include diverse populations in such strategies and RCTs. This Perspective aims to direct attention to the additional harm from the pandemic as well as a refocus on the unresolved lack of inclusion of diverse populations in conducting RCTs. PMID: 32742146 [PubMed - in process]
Source: Ethnicity and Disease - Category: International Medicine & Public Health Tags: Ethn Dis Source Type: research

Related Links:

Authors: Assadiasl S, Fatahi Y, Zavvar M, Nicknam MH Abstract The newly emerged severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has recently caused pandemic Coronavirus Disease-2019 (COVID-19). Considering the serious medical, economic and social consequences of this pandemic and the lack of definite medication and vaccine it is necessary to describe natural immune responses to the SARS-CoV-2 in order to exploit them for treating the patients and monitoring the general population. Moreover, detecting the most immunogenic antigens of the virus is fundamental for designing effective vaccines. Ant...
Source: Human Antibodies - Category: Biochemistry Tags: Hum Antibodies Source Type: research
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020. Related Article(s): Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
Source: JAMA Author Interviews - Category: General Medicine Authors: Source Type: podcasts
[Monitor] Uganda is set to start human trials of the Covid-19 vaccine starting November as the country continues the fight against the pandemic, Ministry of Health officials have said.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
We don ’t know yet how many of the ongoing symptoms could translate to chronic ill health in the future, and that’s worryingAs Covid-19 infection numbers show a welcome downward trend in Melbourne and the city ’s residents look forward to some easing of restrictions, it’s time to consider the longer-term health consequences of the pandemic.More than 27,000 Australians – including some 20,000 Victorians – have been infected with the virus, with almost 900 deaths to date. Many countries are now in the grip of a second wave as the pandemic continues to take a toll on millions of lives aroun...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research Health Science Source Type: news
With an ever-climbing tally of COVID-19 infections, deaths, and calculations about how quickly the virus is spreading, the numbers can start to lose meaning. But one million is a resonant milestone. According to the Johns Hopkins Coronavirus Resource Center, the world has now lost one million lives to the new coronavirus. It’s easy to draw analogies—one million people dying of COVID-19 would be the equivalent of just over the entire population of a country like Djibouti, or just under the populace of Cyprus. Perhaps more sobering would be to think of that number less as an entity and more in terms of the precio...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 News overnight UnitedWeRise20Disaster Source Type: news
The emerging coronavirus disease (COVID-19) caused by SARS-CoV-2 has led to social and economic disruption globally. It is urgently needed to understand the structure and function of the viral proteins for understanding of the viral infection and pathogenesis and development of prophylaxis and treatment strategies. Coronavirus non-structural protein 1 (nsp1) is a notable virulence factor with versatile roles in virus-host interactions and exhibits unique characteristics on sequence, structure, and function mode. However, the roles and characteristics of SARS-CoV-2 nsp1 are currently unclear. Here, we analyze the nsp1 of SA...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
This study provides useful insights for the identification of potential non-pathogenic (to humans) surrogates to understand inactivation kinetics and their use in experimental validation of UV-C disinfection systems. This approach can be used to narrow the number of surrogates used in testing UV-C inactivation of other human and animal ssRNA viral pathogens for experimental validation that can save cost, labor and time.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
There are few things as powerful as avoidance learning. Touch a hot stove once and you’re not likely to do it again. Cross against the light and almost get hit by a car and you’re going to be a lot more careful the next time. But when it comes to the U.S. response to COVID-19? Not so much. You’d have thought that the sight of overflow hospital tents and refrigerated trucks to hold victims’ bodies in New York would have been enough to scare us all straight in mid-March and early April, when infection rates peaked at 32,000 new cases a day, or nearly 10 cases per 100,000 residents—making social ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news
Today when children are under serious threat from Covid-19, the 30th anniversary of the Children's Summit is a highly appropriate time for countries to renew and update the vows they made then. Credit: Manipadma Jena/IPSBy Richard JollyBRIGHTON, United Kingdom, Sep 28 2020 (IPS) On the eve of the UN’s 75th anniversary, Antonio Guterres, the UN’s Secretary-General has declared that the coronavirus pandemic is the world’s top security threat. He has called for action – for greater international co-operation in controlling outbreaks and developing an affordable vaccine, available to all. Such action is...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Development & Aid Education Headlines Health Source Type: news
Global initiative will supply 120m rapid antigen tests to low- and middle-income countriesCoronavirus – latest updatesSee all our coronavirus coverageTests for Covid-19 that show on-the-spot results in 15 to 30 minutes are about to be rolled out across the world, potentially saving many thousands of lives and slowing the pandemic in both poor and rich countries.In a triumph for a global initiative to get vital drugs and vaccines to fight the virus, 120m rapid antigen tests from two companies will be supplied to low- and middle-income countries for $5 ( £3.90) each or even less.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news World Health Organization European commission Infectious diseases Medical research Source Type: news
More News: African Health | Clinical Trials | Coronavirus | COVID-19 | International Medicine & Public Health | Pandemics | Vaccines